GENOMAS

GENOMAS® is a biopharmaceutical company applying DNA-guided medicine to clinical practice, with its products used for personalized prescriptions in the treatment of mental illnesses, diabetes, and cardiovascular diseases (CVD). Our products eliminate trial-and-error prescribing through DNA-guided medications, enabling physicians to treat with unprecedented precision, avoid significant drug side effects, improve efficacy, and enhance patient compliance. The core applications are pharmacotherapy for mood and thought disorders in mental illnesses, as well as cardiometabolic risk in diabetes and cardiovascular diseases. These products were co-developed with three leading medical institutions in Connecticut: Hartford Hospital, Central CT Life and Hospital Research Institute, and the University of Puerto Rico School of Medicine.